Equities

4Cable TV International Inc

CATV:PKC

4Cable TV International Inc

Actions
  • Price (USD)0.0017
  • Today's Change0.000 / -15.00%
  • Shares traded7.42m
  • 1 Year change+466.67%
  • Beta9.9133
Data delayed at least 15 minutes, as of May 31 2024 20:58 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

4Cable TV International, Inc. combines integrative and complimentary care services to promote better, longer, and healthier lives. The Company focuses to build cultivation facilities out of container pods. The Company also sells hemp seeds, hemp flower and biomass, and cannabidiol (CBD) products. The Company’s subsidiaries include Healthcare & Wellness Clinics of America, LLC, which is engaged in aesthetic services, alternative, lifestyle medicine; Healthcare & Wellness of Florida, LLC, which is engaged in medicine and chiropractic care in Florida; Get Medicated, LLC, which is engaged in the sale of CBD flower and Delta 8 products; Corporation Clinic, Inc., which is a distributor of CBD products; CIGN, LLC, which is engaged in the cultivation and sale of hemp seedlings, seeds, and flower; and Green Bros, S.A.S, which is a holder of licenses pertaining to the growth and sale of cannabis in Colombia.

  • Revenue in USD (TTM)758.68k
  • Net income in USD-3.14m
  • Incorporated2007
  • Employees0.00
  • Location
    4Cable TV International Inc1248 Highway 501 BusinessCONWAY 29526United StatesUSA
  • Phone+1 (843) 347-4933
  • Websitehttps://www.4cable.tv/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Pulmatrix Inc11.68m-8.85m6.83m22.00--0.3591--0.5845-2.42-2.423.205.210.3517--17.84531,090.90-26.63-46.91-30.21-58.12-----75.73-238.04----0.00--20.21116.6225.03--104.29--
Kazia Therapeutics Ltd (ADR)15.01k-13.61m6.85m12.00--0.7396--456.72-0.8257-0.82570.00080.35150.0007--73.97---63.98-46.35-82.39-54.75-----90,714.45-497.17----0.1297--979.43-28.3118.19------
Hepion Pharmaceuticals Inc0.00-38.52m6.90m22.00--1.18-----9.49-9.490.001.370.00----0.00-117.64-61.43-145.05-68.82-----------3,240.310.00-------7.92------
Longeveron Inc978.00k-21.62m6.98m23.00--0.9109--7.14-9.58-9.580.42971.210.0621--7.1442,521.74-132.19-63.15-184.16-75.6848.4733.70-2,129.24-441.02----0.00---41.98-19.78-17.92--26.80--
Trevena Inc3.14m-40.15m7.15m23.00------2.28-2.71-2.710.2107-0.79990.0904----136,478.30-115.65-55.93-148.14-66.3548.04---1,279.01-3,134.41---15.391.88--847.61-11.4324.93---24.67--
4Cable TV International Inc758.68k-3.14m7.20m0.00------9.49-0.0624-0.06240.0157-0.04121.071.8425.22---441.73-82.30---308.1029.92---414.41-47.620.0064-0.5271-----0.0914---731.54------
Cyclerion Therapeutics Inc0.00-10.95m7.24m1.00--0.6726-----4.380.29040.003.970.00----0.00-95.95-72.70-158.12-86.96-------2,565.62----0.00---100.00--30.98------
22nd Century Group Inc29.75m-62.89m7.30m64.00------0.2455-40.02-97.9317.94-3.230.405.905.47464,796.90-66.29-46.78-92.49-54.18-33.09-2.11-165.75-107.950.4284-3.674.76---20.494.03-76.94--53.60--
Intelligent Bio Solutions Inc2.83m-10.03m7.33m17.00--0.6151--2.59-64.14-64.144.603.820.20412.697.77166,299.40-72.67-80.65-107.67-224.8423.33---356.09-948.541.87--0.0451--187.51367.97-28.00------
Healthy Extracts Inc2.56m-2.76m7.38m----48.67--2.88-0.9512-0.95120.88190.05120.94280.503532.10---101.47-53.78-375.65-146.6568.4645.68-107.63-87.530.1293-2.220.879--10.41105.93-151.54------
Entero Therapeutics Inc0.00-6.44m7.43m15.00--0.3379-----51.90-51.900.0038.450.00----0.00-12.74-295.92-14.01-1,599.51-----------265.690.0802-------7.55------
Paranovus Entertainment Technology Ltd51.46m-42.62m7.48m80.00--0.7009--0.1454-7.16-7.499.891.461.1859.614.15643,209.90-91.12-23.19-119.36-27.214.9223.09-77.15-24.253.97-2,465.220.00--9.689.80-45.84---21.93--
BioNexus Gene Lab Corp9.78m-2.66m7.51m30.00--0.8032--0.7678-0.14-0.140.6510.52891.018.555.80---27.53-3.83-33.16-5.0213.5614.55-27.25-3.043.98-162.450.00---10.60115.07-638.56--30.40--
Integrated BioPharma, Inc.50.57m-116.00k7.52m141.00--0.397935.490.1488-0.0041-0.00411.670.62831.884.4510.76358,617.00-0.43115.51-0.569827.947.0912.09-0.22946.441.02-9.000.001---9.913.00-101.35---14.03--
eFFECTOR Therapeutics Inc0.00-34.63m7.53m14.00--7.55-----13.31-13.310.000.21190.00----0.00-141.18-----------------17.120.9581---100.00---58.00------
Cadrenal Therapeutics Inc-100.00bn-100.00bn7.54m3.00------------------------------------------------------------
Data as of May 31 2024. Currency figures normalised to 4Cable TV International Inc's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.